| Annual Financials | 2024 | 2025 | 2026 | TTM |
Revenue  | 25 | 38 | 23 | 0 |
| Expenses | 21 | 32 | 26 | 0 |
| EBITDA | 5 | 7 | -4 | 0 |
| Operating Profit % | 19 % | 17 % | -17 % | 0 % |
| Depreciation | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 0 |
| Profit Before Tax | 4 | 5 | -5 | 0 |
| Tax | 2 | 1 | 0 | 0 |
| Net Profit | 3 | 4 | -5 | 0 |
| EPS in ₹ | 3.47 | 3.67 | -3.41 | 0.00 |
Medicamen Organics
Medicamen Organics
21.40
-1.75
(-7.56%)
Market Cap
25.04 Cr
PE Ratio
-7.02
Volume
2,000.00
Day High - Low
21.40 - 21.40
52W High-Low
49.70 - 19.50
Key Fundamentals
Market Cap
25.04 Cr
EPS
-3.41
PE Ratio
-7.02
PB Ratio
0.98
Book Value
23.61
EBITDA
-3.75
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
13.28
Debt to Equity
0.55
Actual
Company News
View All News
Medicamen Organics reports FY26 net loss
4 days ago
4 days agoMedicamen Organics reported a consolidated net loss of ₹401.94 lakh for FY26 against a profit of ₹404.71 lakh in FY25. Revenue fell to ₹2270.91 lakh from ₹3828.27 lakh.
Medicamen Organics Limited approved an amended Code of Practices for Fair Disclosure of UPSI on May 29, 2026. The code is effective immediately and has been uploaded to the company's website.
Medicamen Organics disclosed a valuation report by M/s Jhamb & Associates for its EGM scheduled on May 23, 2026. The report is available on the company website.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,782.10 | #1 4,27,585.49 | 37.30 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.37 | |
6,679.00 | 1,77,306.46 | 67.97 | 10,560.00 | 8.73 | 2,520 | 13.44 | 46.75 | |
4,376.50 | 1,48,120.65 | 69.16 | 13,886.20 | 20.34 | 2,138 | -26.91 | 50.11 | |
1,380.70 | 1,11,530.28 | 28.76 | 27,711.70 | -2.46 | 3,783 | -55.32 | 52.65 | |
1,089.00 | 1,09,578.88 | 21.14 | 26,719.70 | 13.65 | 5,242 | 7.82 | 68.91 | |
1,268.50 | 1,05,874.47 | 25.35 | 33,593.30 | -0.44 | 3,998 | -86.05 | 41.47 | |
2,257.90 | 1,03,195.79 | #1 19.30 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 45.17 | |
2,341.50 | 96,658.31 | 50.52 | 14,277.60 | 12.03 | 1,750 | 31.75 | 50.42 | |
1,454.70 | 84,489.21 | 23.88 | 33,384.70 | 3.21 | 3,376 | 1.99 | 48.90 | |
1,422.80 | 76,810.79 | 84.57 | 6,812.90 | #1 21.03 | 884 | 21.18 | 76.00 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-40.91 %
Net Income Growth
-232.00 %
Cash Flow Change
-24.04 %
ROE
-22.79 %
ROCE
-38.67 %
EBITDA Margin (Avg.)
-194.61 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 38 | 59 | 52 |
| Fixed Assets | 10 | 10 | 14 |
| Current Assets | 27 | 45 | 37 |
| Capital Work in Progress | 0 | 2 | 0 |
| Investments | 0 | 0 | 11 |
| Other Assets | 28 | 47 | 0 |
| Total Equity & Liabilities | 38 | 59 | 52 |
| Current Liabilities | 22 | 27 | 22 |
| Non Current Liabilities | 2 | 2 | 1 |
| Total Equity | 15 | 31 | 29 |
| Reserve & Surplus | 7 | 18 | 17 |
| Share Capital | 9 | 12 | 12 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | 0 | 4 |
| Investing Activities | -0 | -2 |
| Operating Activities | -4 | -5 |
| Financing Activities | 4 | 11 |
Share Holding
| % Holding | Feb 2024 | Jun 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Jan 2026 | Mar 2026 |
| Promoter | 81.21 % | 59.69 % | 59.69 % | 59.73 % | 59.73 % | 61.27 % | 59.73 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.07 % | 0.07 % |
| DIIs | 0.00 % | 0.27 % | 0.07 % | 0.10 % | 0.00 % | 3.55 % | 1.64 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 13.85 % | 28.27 % | 28.79 % | 30.58 % | 28.75 % | 30.79 % |
| Others | 18.79 % | 26.19 % | 11.97 % | 11.38 % | 9.69 % | 6.36 % | 7.78 % |
| No of Share Holders | 34 | 34 | 379 | 460 | 507 | 515 | 540 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 68.75 | 65.00 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 53.10 | 53.80 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 30.40 | 35.10 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 30.10 | 28.00 |
| 09 Apr 2026 |  Extraordinary General Meeting | NA | 09 Apr 2026 | 22.00 | 28.00 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 24.45 | 24.05 |
Technical Indicators
RSI(14)
Neutral 39.75
ATR(14)
Volatile 1.33
STOCH(9,6)
Oversold 11.94
STOCH RSI(14)
Oversold 19.18
MACD(12,26)
Bearish -0.57
ADX(14)
Weak Trend 22.02
UO(9)
Bearish 38.53
ROC(12)
Downtrend And Accelerating -10.96
WillR(14)
Neutral -51.33
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
